Check out our most popular compounded medications! Get Started
Mesalamine 200 mg Slow Release Capsules, formulated with Methocel E4M, are designed to gradually release the active ingredient over an extended period. This controlled-release mechanism offers sustained therapeutic effects, reduces the need for frequent dosing, and enhances patient compliance. These capsules are used in the treatment of Ulcerative Colitis, Crohn's Disease, Proctitis, Proctosigmoiditis, and Diverticulitis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Mesalamine 200 mg Slow Release Capsules are a specialized prescription medication primarily used in the treatment of inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. This unique formulation incorporates Methocel E4M, a controlled-release polymer, which ensures a gradual and sustained release of the active ingredient, mesalamine, over an extended period of time. This slow-release mechanism allows for a more consistent therapeutic effect, reducing the risk of side effects associated with higher doses of the medication.
These capsules are designed to be taken orally, typically once a day, as per the prescribed dosage by your healthcare provider. It is crucial to adhere to the prescribed dosage and not to take more or less than recommended. To minimize the risk of stomach upset, it is advised to take this medication with food or a full glass of water.
Mesalamine 200 mg Slow Release Capsules work by reducing inflammation in the bowel, thereby improving symptoms associated with inflammatory bowel diseases. However, like all medications, it may have some side effects. Common side effects include nausea, vomiting, diarrhea, and headache. If you experience any of these or other side effects, it is important to contact your healthcare provider immediately.
If you have any queries or concerns regarding Mesalamine 200 mg Slow Release Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of experienced and dedicated pharmacists is always here to assist you with your medication needs and to provide you with the most accurate and up-to-date information.
Mesalamine 200 mg Slow Release Capsules, formulated with Methocel E4M, a type of controlled-release polymer, are designed to gradually release the encapsulated medication over an extended period of time. This formulation offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
These capsules may interact with other medications, supplements, or herbs you may be taking. It is crucial to inform your doctor about all other medications you use, including vitamins and herbs. Do not discontinue any medications without first consulting your doctor.
Mesalamine 200 mg Slow Release Capsules may interact with certain antibiotics, such as ampicillin, cefaclor, and ciprofloxacin. Interactions may also occur with certain antifungal medications, such as fluconazole and itraconazole.
Interactions may also occur with certain anti-inflammatory medications, such as ibuprofen and naproxen, and certain antacids, such as aluminum hydroxide and magnesium hydroxide.
These capsules may also interact with certain diuretics, such as furosemide and hydrochlorothiazide, and certain blood pressure medications, such as lisinopril and losartan.
Interactions may also occur with certain immunosuppressants, such as cyclosporine and tacrolimus, and certain chemotherapy medications, such as methotrexate and vinblastine.
Mesalamine 200 mg Slow Release Capsules may also interact with certain anticonvulsants, such as phenytoin and valproic acid, and certain antidepressants, such as amitriptyline and fluoxetine.
Interactions may also occur with certain antihistamines, such as diphenhydramine and loratadine, and certain anticoagulants, such as warfarin and heparin.
These capsules may also interact with certain hormones, such as estrogens and progestins, and certain vitamins, such as vitamin B12 and vitamin D.
Mesalamine 200 mg Slow Release Capsules may also interact with certain herbal supplements, such as ginkgo biloba and St. John's wort.
It is important to inform your doctor about all medications, supplements, and herbs you are taking before starting Mesalamine 200 mg Slow Release Capsules. If you have any questions, please consult your healthcare provider.
Mesalamine 200 mg Slow Release Capsules are a specialized formulation designed to treat various inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. The active ingredient, mesalamine, is an anti-inflammatory medication that targets inflammation in the intestinal lining. The unique feature of these capsules is their slow-release formulation, which is achieved through the use of Methocel E4M, a controlled-release polymer. This design allows for a gradual and extended release of the medication, providing a more sustained therapeutic effect over time.
When using Mesalamine 200 mg Slow Release Capsules, it is crucial to follow the prescribed dosage by your healthcare provider. The capsules should be consumed with food and must be swallowed whole without chewing or crushing. This is to ensure the controlled-release mechanism is not disrupted. Consistency in the timing of medication intake each day is also important to maintain a steady release rate of the medication.
While Mesalamine 200 mg Slow Release Capsules are generally well-tolerated, they may cause some side effects such as nausea, vomiting, stomach pain, and headache. If you experience any of these symptoms, it is advised to contact your healthcare provider immediately. Furthermore, if you are pregnant or breastfeeding, it is important to inform your doctor as the safety of this medication for these specific populations has not been fully established.
Understanding your medication is an important aspect of managing your health. If you have any queries or concerns about Mesalamine 200 mg Slow Release Capsules, do not hesitate to reach out to your healthcare provider or pharmacist. They can provide you with comprehensive information about how this medication works and how it can help manage your inflammatory bowel disease.
Mesalamine 200 mg Slow Release Capsules, formulated with Methocel E4M, a controlled-release polymer, are designed to gradually release the encapsulated medication over an extended period. This slow-release mechanism offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
These capsules have been used off-label for the treatment of various conditions including rheumatoid arthritis, psoriasis, ankylosing spondylitis, and Behcet's disease. They have also been employed in the treatment of microscopic colitis, pouchitis, radiation proctitis, ulcerative jejunoileitis, and ulcerative colitis-associated colorectal cancer. Furthermore, they have been used to manage non-inflammatory bowel diseases such as irritable bowel syndrome and functional dyspepsia. Acute exacerbations of ulcerative colitis and Crohn's disease have also been treated with Mesalamine 200 mg Slow Release Capsules.
However, it is crucial to note that the safety and efficacy of Mesalamine 200 mg Slow Release Capsules for these off-label uses have not been definitively established. Therefore, patients and prescribers should thoroughly discuss the potential risks and benefits of using this formulation for these conditions before initiating treatment. For any queries or concerns, please do not hesitate to contact us at Bayview Pharmacy.
Mesalamine 200 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time.
The controlled-release polymer, Methocel E4M, is designed to gradually release the encapsulated medication over an extended period of time. This offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance for medications requiring a controlled and prolonged release profile.
The benefits of using Mesalamine 200 mg Slow Release Capsules include sustained therapeutic effects, reduced dosing frequency, and improved patient compliance. This is due to the controlled and prolonged release profile of the medication.
The slow release mechanism works by gradually releasing the active ingredient over an extended period of time. This is achieved through the use of a controlled-release polymer, Methocel E4M, which encapsulates the medication.
'Improved patient compliance' means that patients are more likely to take their medication as prescribed. This is because the slow release formulation reduces the frequency of dosing, making it easier for patients to adhere to their medication regimen.
The dosing frequency of Mesalamine 200 mg Slow Release Capsules is reduced compared to other formulations. The exact dosing frequency will depend on the specific instructions provided by your healthcare provider.
'Sustained therapeutic effects' means that the medication continues to have its intended therapeutic effect over an extended period of time. This is due to the slow release of the active ingredient from the capsule.
Not everyone can take Mesalamine 200 mg Slow Release Capsules. It's important to discuss your medical history and current medications with your healthcare provider before starting any new medication.
As with any medication, there may be side effects associated with Mesalamine 200 mg Slow Release Capsules. It's important to discuss potential side effects with your healthcare provider before starting this medication.
No, you should not stop taking Mesalamine 200 mg Slow Release Capsules without first consulting your healthcare provider. Stopping your medication prematurely may lead to a relapse of your symptoms.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
